You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1,210.7% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.2 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 14.1 | 0.0 |
Price / Book value | 0.8 |
Latest | Forecast | |
---|---|---|
Revenue | 68.5% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2017-12-31 | 0.99 | -12.97 | -453.23p | -1.6 | 0.0 | n/a | n/a | 0.0% |
2018-12-31 | 1.94 | -12.40 | -6,680.25p | 0.0 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 0.67 | -10.92 | -1,000.00p | -0.1 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 0.34 | -23.47 | -52.00p | -0.5 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 0.58 | -6.11 | -7.00p | -2.6 | 0.0 | n/a | n/a | 0.0% |
Midatech taps Stephen Parker as its new chairman Sharecast News | 10 Jun |
---|---|
Midatech extends work with Janssen to another experimental molecule Sharecast News | 09 Mar |
Midatech Pharma interim losses narrow Sharecast News | 17 Sep |
MTX110 Development for the Treatment of Glioma | 21-Jun-22 07:00 |
---|---|
Directorate Change | 20-Jun-22 18:00 |
Result of 2022 Annual General Meeting | 20-Jun-22 14:36 |
Retirement of Chairman and Proposed New Chairman | 10-Jun-22 07:00 |
MTX110 Study to be Presented at ISPNO 2022 | 10-Jun-22 07:00 |